ST先鋒(300163.SZ):2024年淨虧損970.13萬元 同比減虧90.26%
格隆匯4月29日丨ST先鋒(300163.SZ)發佈2024年年度報告,本報告期,公司確認歸屬於上市公司股東的淨利潤爲-970.13萬元,同比減虧90.26%。公司淨利潤爲負值,主要原因是:爲進一步優化公司產業投資結構,公司在報告期內剝離了部分子公司。報告期內公司實現營業收入2.59億元,同比上升2.64%,在不斷變化的市場環境下,基本保持了上市公司主營業務的穩定,公司主營業務、核心競爭力未發生重大不利變化,與行業趨勢基本一致,公司主要財務指標未發生重大不利變化,不存在產能過剩、持續衰退或者技術替代等情形,公司持續經營能力不存在重大風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.